JOIN THE FIGHT AGAINST ALZHEIMER’S DISEASE-THE NERAMEXANE STUDY
Alzheimer’s disease Clinical research Trial
by Risa Levovsky
Caregiver-Journalist-Advocate for successful Aging
www.alzheimers-tips.com
Do you know someone who has moderate to severe Alzheimer’s disease?
If so, now is the time to consider participation in a clinical trial
that may play an important role in providing a better treatment
option.
What information can you provide about the Neramexane Study?
Neramexane is an investigational drug in development in the United
States by Forest Laboratories for the treatment of moderate to
severe Alzheimer’s disease. This study will investigate whether
Neramexane can lessen the impact of Alzheimer’s disease and improve
patients’ abilities to understand and retain information and perform
daily tasks.
What are some of the other benefits of participation in the
Neramexane Study?
The Neramexane study allows you to gain access a new research
treatment before it is widely available. You will receive medical
care from physicians during the study. During this study, you will
learn new information about Alzheimer’s disease and meet other
caregivers and patients with Alzheimer’s disease. The Neramexane
Study is a proactive way of joining the fight against Alzheimer’s, a
disease with no method of prevention and no known cure.
For More information about the study, call 1800-59-STUDY
For the latest behavioral interventions, coping skills, innovative
activity ideas and care management strategies
go to www.alzheimers-tips.com